Daniel John Renouf, James T. Topham, Jonathan M. Loree, Dongsheng Tu, David F. Schaeffer, Jennifer J. Knox, Petr Kavan, Derek J. Jonker, Stephen Welch, Felix Couture, Frederic Lemay, Mustapha Tehfe, Mohammed Harb, Nathalie Aucoin, Yoo-Joung Ko, Patricia A. Tang, Pan Du, Shidong Jia, Sharlene Gill, Christopher J. O'Callaghan. "Concurrent mutations in DNA damage repair genes
            <i>BRCA1</i>
            ,
            <i>POLE</i>
            ,
            <i>ATM</i>
            and
            <i>FANCA</i>
            to predict overall and progression-free survival for patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with chemotherapy in combination with dual checkpoint inhibition in the CCTG randomized PA.7 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4178